Sign inGet started

KYTX

Kyverna Therapeutics, Inc.CIK 1994702 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
22

AI insights for KYTX PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for KYTX
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Aktar MertDirector5$0$02026-05-27
Shaw ChristiExecutive Chairperson8$0$02026-05-27
Cohen Fred EDirector, 10% Owner8$0$02026-05-27
CLARK IAN TDirector4$0$02026-05-27
SEIDENBERG BETH CDirector, 10% Owner11$1000.0K$02026-05-27
Martini Gregory S.Chief Financial Officer1$0$02026-05-18
Dac NadiaChief Commercial Officer1$0$02026-05-04
GEHCHAN NAJISee Remarks3$0$02026-03-13
Biddle Warner WestonChief Executive Officer4$0$02026-03-13
GRASSO MARCChief Financial Officer3$0$02026-03-13
Emany Sravan KumarDirector2$0$02026-02-24
Miller Andrew CraigDirector2$0$02026-02-24
Pujols MayobanexChief Technology Officer1$0$02026-02-09
Westlake BioPartners Opportunity Fund I, L.P.10% Owner1$1000.0K$02025-12-18
Walker Karen MarieChief Technology Officer7$0$292.8K2025-12-15
SPIEGELMAN DANIEL KDirector2$0$02025-05-29
Jones Ryan AlexanderChief Financial Officer6$0$02025-04-11
GILEAD SCIENCES, INC.10% Owner4$20.02M$02024-02-12
Northpond Ventures III GP, LLCOther3$9.90M$02024-02-12
Westlake BioPartners GP I, LLC10% Owner6$0$02024-02-12
Bain Capital Life Sciences Fund III, L.P.10% Owner3$9.90M$02024-02-12
Vida Ventures GP III, L.L.C.10% Owner6$5.57M$02024-02-12

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Aktar MertDirector A Award deriv2026-05-272026-05-2920,582— $020,582SEC↗
SEIDENBERG BETH CDirector A Award deriv2026-05-272026-05-2920,582— $020,582SEC↗
Cohen Fred EDirector A Award deriv2026-05-272026-05-2920,582— $020,582SEC↗
CLARK IAN TDirector A Award deriv2026-05-272026-05-2920,582— $020,582SEC↗
Aktar MertDirector A Award2026-05-272026-05-295,093— $021,727SEC↗
Shaw ChristiExecutive Chairperson F Tax w/h2026-05-272026-05-294,194$8.59 $36.0K66,741SEC↗
SEIDENBERG BETH CDirector A Award2026-05-272026-05-295,093— $021,727SEC↗
Cohen Fred EDirector A Award2026-05-272026-05-295,093— $021,727SEC↗
CLARK IAN TDirector A Award2026-05-272026-05-295,093— $021,727SEC↗
Martini Gregory S.Chief Financial Officer A Award deriv2026-05-182026-05-20325,000— $0325,000SEC↗
Dac NadiaChief Commercial Officer A Award deriv2026-05-042026-05-06300,000— $0300,000SEC↗
Biddle Warner WestonChief Executive Officer A Award deriv2026-03-132026-03-17350,000— $0350,000SEC↗
GRASSO MARCChief Financial Officer A Award deriv2026-03-132026-03-1765,000— $065,000SEC↗
GEHCHAN NAJISee Remarks A Award deriv2026-03-132026-03-17105,000— $0105,000SEC↗
Biddle Warner WestonChief Executive Officer A Award2026-03-132026-03-1758,000— $058,000SEC↗
GRASSO MARCChief Financial Officer A Award2026-03-132026-03-1710,000— $010,000SEC↗
GEHCHAN NAJISee Remarks A Award2026-03-132026-03-1718,000— $018,000SEC↗
Emany Sravan KumarDirector A Award deriv2026-02-242026-02-2642,945— $042,945SEC↗
Miller Andrew CraigDirector A Award deriv2026-02-242026-03-0442,945— $042,945SEC↗
Emany Sravan KumarDirector A Award2026-02-242026-02-2611,006— $011,006SEC↗
Miller Andrew CraigDirector A Award2026-02-242026-03-0411,006— $011,006SEC↗
Pujols MayobanexChief Technology Officer A Award deriv2026-02-092026-02-11300,000— $0300,000SEC↗
Shaw ChristiExecutive Chairperson A Award deriv2026-01-122026-01-14185,000— $0185,000SEC↗
Shaw ChristiExecutive Chairperson A Award2026-01-122026-01-1424,301— $070,935SEC↗
Shaw ChristiExecutive Chairperson A Award2026-01-122026-01-1430,000— $046,634SEC↗
Westlake BioPartners Opportuni10% Owner P Buy2025-12-182025-12-22133,333$7.50 $1000.0K869,317SEC↗
SEIDENBERG BETH CDirector P Buy2025-12-182025-12-22133,333$7.50 $1000.0K869,317SEC↗
Walker Karen MarieChief Technology Officer M Exercise deriv2025-12-152025-12-1723,998— $085,865SEC↗
Walker Karen MarieChief Technology Officer S Sale2025-12-152025-12-1723,998$12.20 $292.8K22,636SEC↗
Walker Karen MarieChief Technology Officer M Exercise2025-12-152025-12-1723,998$4.83 $115.9K46,634SEC↗
GRASSO MARCChief Financial Officer A Award deriv2025-06-302025-07-01450,000— $0450,000SEC↗
Cohen Fred EDirector, 10% Owner A Award deriv2025-05-292025-06-0265,351— $065,351SEC↗
CLARK IAN TDirector A Award deriv2025-05-292025-06-0265,351— $065,351SEC↗
Aktar MertDirector A Award deriv2025-05-292025-06-0265,351— $065,351SEC↗
SPIEGELMAN DANIEL KDirector A Award deriv2025-05-292025-06-0265,351— $065,351SEC↗
SEIDENBERG BETH CDirector, 10% Owner A Award deriv2025-05-292025-06-0265,351— $065,351SEC↗
Shaw ChristiDirector A Award deriv2025-05-292025-06-0265,351— $065,351SEC↗
Cohen Fred EDirector, 10% Owner A Award2025-05-292025-06-0216,634— $016,634SEC↗
CLARK IAN TDirector A Award2025-05-292025-06-0216,634— $016,634SEC↗
Aktar MertDirector A Award2025-05-292025-06-0216,634— $016,634SEC↗
SPIEGELMAN DANIEL KDirector A Award2025-05-292025-06-0216,634— $016,634SEC↗
SEIDENBERG BETH CDirector, 10% Owner A Award2025-05-292025-06-0216,634— $016,634SEC↗
Shaw ChristiDirector A Award2025-05-292025-06-0216,634— $016,634SEC↗
Walker Karen MarieChief Technology Officer A Award2025-04-112025-04-1513,000— $022,636SEC↗
Jones Ryan AlexanderChief Financial Officer A Award2025-04-112025-04-1512,000— $055,950SEC↗
Shaw ChristiDirector A Award deriv2025-02-142025-02-1938,679— $038,679SEC↗
GEHCHAN NAJISee Remarks A Award deriv2025-01-222025-01-24425,000— $0425,000SEC↗
Aktar MertDirector A Award deriv2024-10-212024-10-2487,741— $087,741SEC↗
Shaw ChristiDirector A Award deriv2024-09-162024-09-1866,592— $066,592SEC↗
Biddle Warner WestonChief Executive Officer A Award deriv2024-09-162024-09-182,579,259— $02,579,259SEC↗
Walker Karen MarieChief Technology Officer M Exercise deriv2024-06-062024-06-109,636— $082,648SEC↗
Walker Karen MarieChief Technology Officer M Exercise2024-06-062024-06-109,636$4.42 $42.6K9,636SEC↗
Jones Ryan AlexanderChief Financial Officer M Exercise deriv2024-05-282024-05-297,146— $02,192SEC↗
Jones Ryan AlexanderChief Financial Officer M Exercise deriv2024-05-282024-05-2910,870— $00SEC↗
Jones Ryan AlexanderChief Financial Officer M Exercise2024-05-282024-05-297,146$0.73 $5.2K43,950SEC↗
Jones Ryan AlexanderChief Financial Officer M Exercise2024-05-282024-05-2910,870$0.73 $7.9K36,804SEC↗
Walker Karen MarieChief Technology Officer A Award deriv2024-04-112025-04-1580,000— $080,000SEC↗
Jones Ryan AlexanderChief Financial Officer A Award deriv2024-04-112025-04-1574,000— $074,000SEC↗
Biddle Warner WestonChief Executive Officer A Award deriv2024-04-112025-04-15332,500— $0332,500SEC↗
Northpond Ventures III GP, LLCOther C Conversion deriv2024-02-122024-02-1212,767,776— $00SEC↗
GILEAD SCIENCES, INC.10% Owner C Conversion deriv2024-02-122024-02-137,746,139— $00SEC↗
GILEAD SCIENCES, INC.10% Owner C Conversion deriv2024-02-122024-02-136,890,744— $00SEC↗
Bain Capital Life Sciences Fun10% Owner C Conversion deriv2024-02-122024-02-1412,351,087— $00SEC↗
Westlake BioPartners GP I, LLC10% Owner C Conversion deriv2024-02-122024-02-144,401,771— $00SEC↗
Westlake BioPartners GP I, LLC10% Owner C Conversion deriv2024-02-122024-02-143,349,538— $00SEC↗
Westlake BioPartners GP I, LLC10% Owner C Conversion deriv2024-02-122024-02-144,006,624— $00SEC↗
Westlake BioPartners GP I, LLC10% Owner C Conversion deriv2024-02-122024-02-148,830,901— $00SEC↗
SEIDENBERG BETH CDirector, 10% Owner C Conversion deriv2024-02-122024-02-143,349,538— $00SEC↗
SEIDENBERG BETH CDirector, 10% Owner C Conversion deriv2024-02-122024-02-144,401,771— $00SEC↗
SEIDENBERG BETH CDirector, 10% Owner C Conversion deriv2024-02-122024-02-148,830,901— $00SEC↗
SEIDENBERG BETH CDirector, 10% Owner C Conversion deriv2024-02-122024-02-144,006,624— $00SEC↗
Cohen Fred EDirector, 10% Owner C Conversion deriv2024-02-122024-02-147,356,162— $00SEC↗
Cohen Fred EDirector, 10% Owner C Conversion deriv2024-02-122024-02-144,401,771— $00SEC↗
Cohen Fred EDirector, 10% Owner C Conversion deriv2024-02-122024-02-148,830,901— $00SEC↗
Vida Ventures GP III, L.L.C.10% Owner C Conversion deriv2024-02-122024-02-144,401,771— $00SEC↗
Vida Ventures GP III, L.L.C.10% Owner C Conversion deriv2024-02-122024-02-148,830,901— $00SEC↗
Vida Ventures GP III, L.L.C.10% Owner C Conversion deriv2024-02-122024-02-147,356,162— $00SEC↗
Northpond Ventures III GP, LLCOther C Conversion2024-02-122024-02-122,805,426— $02,805,426SEC↗
Northpond Ventures III GP, LLCOther P Buy2024-02-122024-02-12450,000$22.00 $9.90M450,000SEC↗
GILEAD SCIENCES, INC.10% Owner P Buy2024-02-122024-02-13910,000$22.00 $20.02M4,126,119SEC↗
GILEAD SCIENCES, INC.10% Owner C Conversion2024-02-122024-02-133,216,119— $03,216,119SEC↗
Bain Capital Life Sciences Fun10% Owner P Buy2024-02-122024-02-14450,000$22.00 $9.90M3,163,868SEC↗
Bain Capital Life Sciences Fun10% Owner C Conversion2024-02-122024-02-142,713,868— $02,713,868SEC↗
Westlake BioPartners GP I, LLC10% Owner C Conversion2024-02-122024-02-14735,984— $0735,984SEC↗
Westlake BioPartners GP I, LLC10% Owner C Conversion2024-02-122024-02-143,787,940— $03,787,940SEC↗
SEIDENBERG BETH CDirector, 10% Owner C Conversion2024-02-122024-02-14735,984— $0735,984SEC↗
SEIDENBERG BETH CDirector, 10% Owner C Conversion2024-02-122024-02-143,787,940— $03,787,940SEC↗
Cohen Fred EDirector, 10% Owner C Conversion2024-02-122024-02-144,523,924— $04,523,924SEC↗
Vida Ventures GP III, L.L.C.10% Owner P Buy2024-02-122024-02-14583$22.00 $12.8K583SEC↗
Vida Ventures GP III, L.L.C.10% Owner P Buy2024-02-122024-02-14252,553$22.00 $5.56M252,553SEC↗
Vida Ventures GP III, L.L.C.10% Owner C Conversion2024-02-122024-02-144,523,924— $04,523,924SEC↗